Impurose C 10mg/75mg Capsule is a combination pharmaceutical formulation containing Rosuvastatin 10mg and Clopidogrel 75mg, indicated for the management of cardiovascular conditions requiring both lipid-lowering and antiplatelet therapy. Rosuvastatin, a potent HMG-CoA reductase inhibitor, effectively reduces low-density lipoprotein cholesterol (LDL-C) and triglycerides while modestly increasing high-density lipoprotein cholesterol (HDL-C), thereby contributing to the prevention of atherosclerosis and related cardiovascular events. Clopidogrel, an antiplatelet agent, irreversibly inhibits the P2Y12 component of ADP receptors on platelet surfaces, preventing platelet aggregation and reducing the risk of thrombotic events such as myocardial infarction, stroke, and peripheral arterial disease. The combined use of these agents in Impurose C is particularly beneficial in patients with established coronary artery disease, recent acute coronary syndrome, or those at high risk of atherothrombotic complications. Administration should be under medical supervision, with careful monitoring of lipid profiles, bleeding risk, liver function, and potential drug interactions. Contraindications include active pathological bleeding and hypersensitivity to either component. Adherence to prescribed dosage and lifestyle modifications enhances therapeutic outcomes and reduces cardiovascular morbidity and mortality.